A 2-dose regimen of the vaccine modified vaccinia Ankara-Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for monkeypox virus clade Ib as well as for clade IIb.
Journal article
2026-02-01T00:00:00+00:00
32
302 - 305
3
ISARIC4C Investigators, Humans, Monkeypox virus, Vaccinia virus, Smallpox Vaccine, Antibodies, Viral, Vaccination, Adult, Middle Aged, Female, Male, Young Adult, Antibodies, Neutralizing, Healthy Volunteers, United Kingdom, Mpox, Monkeypox